Schizophrenia is a chronic, severe, and highly heterogeneous psychiatric disorder. Current antipsychotic medications show limited effectiveness in treating negative symptoms and cognitive deficits. Accumulating evidence suggests that dysfunction of inhibitory γ-aminobutyric acid (GABA) neurons, leading to inhibitory circuit dysregulation, plays a pivotal role in the pathophysiology of the disorder. Recent advances in induced pluripotent stem cells (iPSCs) and brain organoid technologies have provided more accurate human-based models of schizophrenia, offering new avenues to investigate the complex neurodevelopmental mechanism of schizophrenia and to explore cell replacement therapies. Preclinical studies have demonstrated that transplantation of specific types of GABAergic interneuron precursors into the brain can selectively improve negative symptoms and cognitive deficits in animal models, highlighting considerable translational potential. However, the transition from bench to bedside still faces multiple technical and ethical challenges, enhancing cell differentiation efficiency, ensuring long-term safety of transplanted cells, achieving precise control and functional integration of neuronal subtypes, understanding circuit-specific contributions to different symptom domains, and establishing rigorous ethical and regulatory frameworks. In summary, inhibitory GABAergic interneuron-based cell therapy provides a novel theoretical and perspective foundation for improving negative and cognitive symptoms of schizophrenia. Despite significant challenges ahead, its prospects remain highly promising.

Schizophrenia is a chronic, severe, and highly heterogeneous psychiatric disorder. Current antipsychotic medications show limited effectiveness in treating negative symptoms and cognitive deficits. Accumulating evidence suggests that dysfunction of inhibitory γ-aminobutyric acid (GABA) neurons, leading to inhibitory circuit dysregulation, plays a pivotal role in the pathophysiology of the disorder. Recent advances in induced pluripotent stem cells (iPSCs) and brain organoid technologies have provided more accurate human-based models of schizophrenia, offering new avenues to investigate the complex neurodevelopmental mechanism of schizophrenia and to explore cell replacement therapies. Preclinical studies have demonstrated that transplantation of specific types of GABAergic interneuron precursors into the brain can selectively improve negative symptoms and cognitive deficits in animal models, highlighting considerable translational potential. However, the transition from bench to bedside still faces multiple technical and ethical challenges, enhancing cell differentiation efficiency, ensuring long-term safety of transplanted cells, achieving precise control and functional integration of neuronal subtypes, understanding circuit-specific contributions to different symptom domains, and establishing rigorous ethical and regulatory frameworks. In summary, inhibitory GABAergic interneuron-based cell therapy provides a novel theoretical and perspective foundation for improving negative and cognitive symptoms of schizophrenia. Despite significant challenges ahead, its prospects remain highly promising.

Objective To study the development characteristics of cavum sepit pellucidun (CSP)in prematures,neonates,infants and adults with MRI.Methods Brain MR images of different subjects including 141 prematures,106 neonates,171 infants and 35 046 adults were observed to determine the incidence and shape of CSP,and to measure its transverse diameter.Results CSP incidences were 100% (141/141)in prematures,97.17% (103/106)in neonates,2.26%(4/177)in infants and 0.82% (287/35 046)in adults respectively,and the CSP was cylinder (44.00%)or triangle in shape (56.00%)in prematures,triangle (76.40%)or fissure in shape (23.60%)in neonates.For infants or adults,each shape accounted for about a third of three kinds of shape respectively.Its mean transverse diameters were 5.7 mm in prematures,4.1 mm in neonates,13.3 mm in infants and 14.3 mm in adults respectivity.Conclusion CSP has different performances at development periods in human being brain.Most close after birth,while fewer remain in the whole life.

Objective To evaluate the value of CT in diagnosis of cervical intervertebral disk herniation. Methods The observation of CT appearances of 146 cases and the size, type, position of cervical intervertebral disk herniation were analyzed. Results ①Cervical intervertebral disk herniation was always multi-segments,often lolated at C4,5and C5,6. ②C5,6was mostly seen (142 cases,97.3%). ③Among centric and lateral type,centic type was mostly seen { 135 cases,92.5%). ④Of 135 cases of centric type,54 cases were mild type (< 2 mm) ,66 cases were moderate type (2 ～ 4 mm) , 15 cases were severe type (> 4 mm). Conclusion CT scan is convenient, efficient,accuracte and the first choice method in diagnosing cervical intervertebral disk herniation.